-Biopure Corporation, Cambridge, USA
Product : HemopureTM.
Source : Polymerised bovine Hb,Africa 2001.
Clinical trial level:Approved for use in South .Application : Clinical use to treat acute anaemia and as alternative to donated blood in transfusion.
-Hemosol Incorporated, Toronto, Canada
Product :HemolinkTM.
Source : Phase III trials completed.
Clinical trial : Phase III trials completed.
Application : Application for use during cardiac surgery filed to regulatory authorities.
-Sangart Incorporated, San Diego, USA
Product : HemospanTM.
Source : Conjugated human Hb.
Clinical trial level: Phase Ib/II initiated in Sweden 2003.
Application : Trials underway in orthopaedic surgery.
-Baxter International,Deerfield, USA
Product : OptroTM.
Source : Cross-linked Hb from genetically modified E. coli bacteria.
Clinical trial level: Phase II trials completed.
Application : Trials completed in patients undergoing surgery in 1999.
No comments:
Post a Comment